R&D Systems™ Recombinant Human CTRP5/C1qTNF5 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human CTRP5/C1qTNF5 Protein is derived from NS0. The Recombinant Human CTRP5/C1qTNF5 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q9BXJ0
• Characterization: Bioactivity
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in HEPES and NaCl.
• Gene ID (Entrez): 114902
• Molecular Weight (g/mol): 25kDa
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived human CTRP5/C1qTNF5 protein Ser16-Ala243,with Gln44Arg substitution and a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10EU per 1μg of the protein by the LAL method.
• Gene Alias: C1q and tumor necrosis factor related protein 5, C1qTNF5, Complement C1q Tumor Necrosis Factor-Related Protein 5 Precursor Variant 3, CTRP5LORDDKFZp586B0621, LORD 6, Myonectin 3
• Product Type: Recombinant Protein
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 200μg/mL in PBS.
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.